AI infrastructure is becoming one of the most competitive areas in tech, driven by fast growth in generative AI, large model training, and demand for GPU cloud computing. CoreWeave (CRWV) and Nebius Group (NBIS) are two strong players, benefitting from this trend. Using the TipRanks Stocks Comparison Tool, we compare CRWV and NBIS. Both stocks currently carry Moderate Buy ratings from analysts. CoreWeave stock offers about 31% upside potential, while Nebius Group stock has a lower upside of around 16%.
Claim 55% Off TipRanks
CWVX: an alternative to margin or options on CRWV
For context, CoreWeave mainly focuses on AI training, visual effects, and heavy batch computing jobs, while Nebius offers a wider AI platform that includes GPUs (Graphics Processing Units), software tools, and cloud services all in one place.
Let’s look at these stocks in detail.
CoreWeave (NASDAQ: CRWV)
Year-to-date, CRWV stock is up more than 40%, recovering after a volatile start to the year. Earlier this month, the company reported its Q1 226 results with strong revenue growth but also a larger-than-expected loss per share and weak guidance.
On the positive side, CoreWeave had its strongest bookings ever, with a huge $99.4 billion backlog and major deals, including a $21 billion commitment from Meta (META) and a multi-year agreement with Anthropic for the Claude AI model. However, concerns remain about heavy spending to expand capacity, which has increased debt levels to about $25 billion.
CoreWeave Stock Forecast
On Wall Street, analysts are mixed but slightly cautious on CRWV stock based on 13 Buys, 10 Holds, and one Sell assigned in the last three months. Recently, DA Davidson’s top-rated analyst Gil Luria downgraded the stock to Hold and cut his price target from $175 to $100. He stated that the company may struggle to deliver strong returns due to weak margins and heavy reliance on debt, even though demand for computing is strong.
On the positive side, Citi’s analyst Tyler Radke raised his target to $158 and kept a Buy rating, expecting strong long-term growth driven by rising AI demand and big cloud spending.
Meanwhile, Bernstein’s Madison Rezaei kept a Sell rating with a $67 target. He pointed out that CoreWeave’s low profit margins and fast growth make it unclear how quickly the company can become profitable.
Nebius Group (NASDAQ: NBIS)
Compared to CoreWeave, NBIS stock has performed even better, rising nearly 130% year-to-date. Nebius uses a vertically integrated model, giving it more control over performance, costs, and scalability.
In Q1 2026, the company reported strong revenue growth of 684% year-over-year to $399 million. However, its adjusted net loss widened to $100.3 million from $83.6 million a year earlier.
Looking ahead, CEO Arkady Volozh said demand for AI computing and cloud services remains strong as more businesses move from testing AI tools to real-world adoption. Notably, Nebius also reaffirmed its full-year 2026 revenue forecast of $3 billion to $3.4 billion, roughly in line with Wall Street expectations.
Nebius Stock Forecast
Similar to CoreWeave, analysts are moderately bullish on NBIS stock backed by six Buys and three Holds assigned in the last three months.
DA Davidson analyst Luria has a Hold rating on NBIS with a $250 price target after the stock’s strong rally over the past year. Luria praised Nebius, highlighting its strong execution, disciplined spending, and broad AI cloud strategy. However, he also said the stock already trades at a premium valuation to its backlog, which could limit near-term upside.
On the positive side, Northland analyst Nehal Chokshi raised his price target on NBIS to $248 from $215 and kept a Buy rating on the stock. He said Nebius delivered stronger-than-expected recurring revenue and profitability in the March quarter. He also believes the company is moving faster in AI software innovation compared to many other AI-as-a-service rivals.
Conclusion
Analysts currently rate both CoreWeave and Nebius stocks as Moderate Buys. Wall Street’s average price target for CoreWeave stands at $132.61, pointing to roughly 31% potential upside, while Nebius carries an average price target of $221.71, implying about 16% upside from current prices.